Demographics and clinical features of patients referred to headache specialists

Canadian Journal of Neurological Sciences

Volumn 33, Issue 2, 2006, Pages 228-234

  Jelinski, Susan E ^a   Becker, Werner J ^a,g   Christie, Suzanne N ^b   Giammarco, Rose ^c   Mackie, Gordon F ^e   Gawel, Marek J ^d   Eloff, Arnolda G ^a   Magnusson, Jane E ^f  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e Richmond Hospital   (Canada)

^f UNIVERSITY OF AUCKLAND   (New Zealand)

^g FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; CHRONIC PAROXYSMAL HEMICRANIA; CLINICAL FEATURE; CLINICAL TRIAL; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISABILITY; DISEASE SEVERITY; EMPLOYMENT; FEMALE; HEADACHE; HEMICRANIA CONTINUA; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MIGRAINE; MULTICENTER STUDY; NEUROLOGY; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; TENSION HEADACHE; TRANSFORMED MIGRAINE;

EID: 33744922389     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100005035     Document Type: Article

References (36)

1. O'Brien B, Goeree R, Streiner D. Prevalence of migraine headache in Canada: a population-based survey. Int J Epidemiol. 1994;23:1020-6.
2. Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA. 1998;279:381-3.
3. Lambert J, Carides GW, Meloche JP, Gerth WC, Marentette MA. Impact of migraine symptoms on health care use and work loss in Canada in patients randomly assigned in a phase III clinical trial. Can J Clin Pharmacol. 2002;9:158-64.
4. Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci. 1993;20:131-7.
5. Swarztrauber K, Lawyer BL. Neurologists 2000: AAN Member Demographic and Practice Characteristics. St. Paul. MN: American Academy of Neurology, 2001.
6. Bailey P, Warren S, Buske L. Highlights of the 2002 Canadian Neurological Society (CNS) manpower survey. Can J Neurol Sci. 2005;32:425-32.
7. Hopkins A, Menken M, DeFriese G. A record of patient encounters in neurological practice in the United Kingdom. J Neurol Neurosurg Psychiatry. 1989;52:436-8.
8. Cockerell OC, Goodridge DM, Brodie D, Sander JW, Shorvon SD. Neurological disease in a defined population: the results of a pilot study in two general practices. Neuroepidemiology. 1996;15:73-82.
9. Wiles CM, Lindsay M. General practice referrals to a department of neurology. J R Coll Physicians Lond. 1996;30:426-31.
10. Bekkelund SI, Albretsen C. Evaluation of referrals from general practice to a neurological department. Fam Pract. 2002;19:297-9.
11. Salvesen R, Bekkelund SI. Aspects of referral care for headache associated with improvement. Headache. 2003;43:779-83.
12. Hu XH, O'Donnell F, Kunkel RS, Gerard G, Markson LE, Berger ML. Survey of migraineurs referred to headache specialists: care, satisfaction, and outcomes. Neurology. 2000;55:141-3.
13. Bekkelund SI, Salvesen R. Are headache patients who initiate their referral to a neurologist satisfied with the consultation? A population study of 927 patients-the North Norway Headache Study (NNHS). Fam Pract. 2001;18:524-7.
14. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia. 1988;8 Suppl 7:51-96.
15. Siberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache. 1994;34:l-7.
16. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology. 1996;47:871-5.
17. Kosinski M, Bayliss MS, Bjorner JB, Ware JE Jr, Garber WH, Batenhorst A, et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res. 2003;12:963-74.
18. Stewart WF, Lipton RB, Whyte J, et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology. 1999;53:988-94.
19. Stewart WF, Lipton RB, Kolodner K, Liberman JN, Sawyer J. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia. 1999;19:107-14; discussion 174.
20. Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 2000;88:4l-52.
21. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24 Suppl 1:89-160.
22. Cassidy EM, Tomkins E, Hardiman O, O'Keane V. Factors associated with burden of primary headache in a specialty clinic. Headache. 2003;43:638-44.
23. Ferrari A, Pasciullo G, Savino G, Cicero AF, Ottani A, Bertolini A, et al. Headache treatment before and after the consultation of a specialized centre: a pharmacoepidemiology study. Cephalalgia. 2004;24:356-62.
24. Gesztelyi G, Bereczki D. Primary headaches in an outpatient neurology headache clinic in East Hungary. Eur J Neurol. 2004;11:389-95.
25. Sheftell FD, Feleppa M, Tepper SJ, Volcy M, Rapoport AM, Bigal ME. Patterns of use of triptans and reasons for switching them in a tertiary care migraine population. Headache. 2004;44:661-8.
26. Gerth WC, Carides GW, Dasbach EJ, Visser WH, Santanello NC. The multinational impact of migraine symptoms on healthcare utilisation and work loss. Pharmacoeconomics. 2001;19:197-206.
27. Von Korff M, Stewart WF, Simon DJ, Lipton RB. Migraine and reduced work performance: a population-based diary study. Neurology. 1998;50:1741-5.
28. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999;159:813-8.
29. Lipton RB, Bigal ME, Kolodner K, Stewart WF, Liberman JN, Steiner TJ. The family impact of migraine: population-based studies in the USA and UK. Cephalalgia. 2003;23:429-40.
30. Lipton RB, Scher AI, Kolodner K, et al. Migraine in the United States: epidemiology and patterns of health care use. Neurology. 2002;58:885-94.
31. Population 15 years and over by highest level of schooling (1981-2001 censuses): Statistics Canada, 2001.
32. Veuillaume De Diego E, Lanteri-Minet M. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT). Cephalalgia. 2004;25:184-90.
33. Nachit-Ouinekh F, Dartigues JF, Henry P, Becg JP, Chastan G, Lemaire N, et al. Use of the headache impact test (HIT-6) in general practice: relationship with quality of life and severity. Eur J Neurol. 2005;12:189-93.
34. Kawata AK, Coeytaux RR, Devellis RF, Finkel AG, Mann JD, Kahn K. Psychometric Properties of the HIT-6 Among Patients in a Headache-Specialty Practice. Headache. 2005;45:638-43.
35. Bigal ME, Rapoport AM, Lipton RB, Tepper SJ, Sheftel FD. Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache. 2003;43:336-42.
36. Bussone G, Usai S, Grazzi L, Rigamonti A, Solari A, D'Amico D. Disability and quality of life in different primary headaches: results from Italian studies. Neurol Sci. 2004;25 Suppl 3:S105-7.